Singer Lori Jenaire is on a mission beyond sales and charting. With the release of her single — which listed in the Top Five Billboard Hot Singles Sales — “As You Are,” a remake of the 1978 Pharaoah Sander’s R&B classic, Jenaire is pledging a portion of all proceeds from its…
Kevin J. Tracey, MD, CEO and president of The Feinstein Institute for Medical Research, is the winner of the Frederik B. Bang Award for his work on controlling inflammation in the treatment of diseases such as a lupus. Bestowed by The International Endotoxin and Innate Immunity Society (IEIIS) as its highest…
Aurinia Pharmaceuticals announced that seven of the 10 patients with lupus nephritis (LN) enrolled in its AURION study, evaluating short-term predictors of clinical response to voclosporin treatment, achieved complete disease remission at 24 weeks. In addition, the company reported that patients who achieved remission at eight weeks continued in remission at 24 weeks.
The monoclonal antibody against interleukin (IL)-6, called PF-04236921, was found to be efficient at reducing severe flares in systemic lupus erythematosus (SLE) patients — particularly in those with high disease activity — when administered at a 10 mg dose. The study, “Efficacy and safety of an interleukin 6 monoclonal antibody for…
Researchers at Temple University Hospital are taking part in a large, global Phase 3 clinical trial to evaluate whether a novel, investigational drug for systemic lupus erythematosus (SLE) is more effective than previously approved medications. This trial (NCT02446912), one of several pivotal and ongoing studies of anifrolumab to treat moderately to severely active SLE,…
Aurinia Pharmaceuticals announced that its AURA-LV clinical trial, assessing voclosporin for the treatment of lupus nephritis (LN), has achieved its primary endpoint at its lower dose — complete disease remission at 24 weeks. Prespecified secondary endpoints at both dose levels were also reached in comparison to placebo, including partial remission as measured…
Consumption of foods rich in docosahexaenoic acid (DHA), an omega-3 fatty acid, can prevent the onset of systemic lupus erythematosus (SLE) and possibly other autoimmune diseases, according to a study published in the journal PLoS One. The study, by Melissa Bates from Michigan State University and colleagues, is titled “Silica-Triggered…
The very first time I stepped onto Californian soil, in 2013, I was instantly in love with the different culture, how I was completely immersed in something so foreign to everything I’d ever known. My wanderlust was born. From that day on, I’ve planned my life around my…
The University of Rochester Medical Center in New York will host a 10th Lupus Education Day on Saturday, Oct. 15, providing a forum for people with systemic lupus erythematosus (SLE) and their caregivers to interact and to better understand the latest developments in treating and managing the disease. “This is a great opportunity…
Large-scale analysis of genome-wide gene expression signatures allows researchers to discriminate between patients with active and inactive systemic lupus erythematosus — and could help physicians in adjusting treatment to control disease activity while minimizing the risk of side effects. The study reporting the method, “Clinical Application of a Modular…